The Development Pathway for Biosimilar Biotherapeutics

The Development Pathway for Biosimilar Biotherapeutics

Bibliographic Details
Main Author:	Marco Zarbin
Format:	Article
Language:	English
Published:	Knowledge E 2020-08-01
Series:	Journal of Ophthalmic & Vision Research
Online Access:	https://doi.org/10.18502/jovr.v15i3.7444

Similar Items

Authorisation of Non-Innovator Biotherapeutic (Biosimilar) Products in the USA
by: A. A. Soldatov, et al.
Published: (2019-03-01)

Regulatory Pathway for Licensing Biotherapeutics in Mexico
by: Carlos A. López-Morales, et al.
Published: (2018-09-01)

Advances in the Development of Biotherapeutics
by: Pedro H. Oliveira, et al.
Published: (2015-01-01)

Enhanced production of recombinant serratiopeptidase in Escherichia coli and its characterization as a potential biosimilar to native biotherapeutic counterpart
by: Vishal Srivastava, et al.
Published: (2019-12-01)

Comparing the original and biosimilar biotherapeutics of the monoclonal antibody eculizumab by intact mass measurement and middle-up mass spectrometry analysis
by: M. B. Degterev, et al.
Published: (2021-03-01)

In silico tools for the development of biotherapeutics
by: Lauer, Timothy Michael
Published: (2016)

Development of particulate carriers for delivery and targeting of biotherapeutics
by: Mohamed, Ahmed Moustafa Aly
Published: (2006)

Development of novel biotherapeutics to treat S. aureus infection
by: Woodman, Sally Elizabeth
Published: (2017)

Anaphylaxis and the inclusion of polysorbates in biotherapeutics
by: Edward Maggio

Posttranslational Modifications and the Immunogenicity of Biotherapeutics
by: Roy Jefferis
Published: (2016-01-01)

Development of novel methods for periplasmic release of biotherapeutic products
by: Krämer, Julia
Published: (2017)

The biosimilar pathway in the USA: An analysis of the innovator company and biosimilar company perspectives and beyond
by: Lin-Chau Chang
Published: (2019-07-01)

Pediatric Dosing and Body Size in Biotherapeutics
by: Hartmut Derendorf, et al.
Published: (2010-12-01)

Cyanobacterial Production of Biopharmaceutical and Biotherapeutic Proteins
by: Nico Betterle, et al.
Published: (2020-03-01)

Functional DNA Aptamers as Biotherapeutic Molecules
by: Orava, Erik
Published: (2013)

Functional DNA Aptamers as Biotherapeutic Molecules
by: Orava, Erik
Published: (2013)

On the Regulatory Approval Pathway of Biosimilar Products
by: Jun Wang, et al.
Published: (2012-03-01)

Ten years of biosimilars in Europe: development and evolution of the regulatory pathways
by: Schiestl M, et al.
Published: (2017-05-01)

Immunogenicity of Biotherapeutics: Causes and Association with Posttranslational Modifications
by: Anshu Kuriakose, et al.
Published: (2016-01-01)

Engineering Components of the Lactobacillus S-Layer for Biotherapeutic Applications
by: Courtney Klotz, et al.
Published: (2018-10-01)

Antibiotic-Free Selection in Biotherapeutics: Now and Forever
by: Charlotte Mignon, et al.
Published: (2015-04-01)

Potentials and limitations of microorganisms as renal failure biotherapeutics
by: Poonam Jain, et al.
Published: (2009-05-01)

Engineering targeted proteins for intracellular delivery of biotherapeutics
by: Pirie, Christopher M
Published: (2013)

Lactobacilli and lactoferrin: Biotherapeutic effects for vaginal health
by: Lucia Bertuccini, et al.
Published: (2018-06-01)

Development of Biosimilars in Brazil
by: Eduardo Braz Pereira Gomes, et al.
Published: (2016-06-01)

Recent Advances in Assessing Immunogenicity of Therapeutic Proteins: Impact on Biotherapeutic Development
by: Yanmei Lu, et al.
Published: (2016-01-01)

Molecular Interaction Characterization Strategies for the Development of New Biotherapeutic Antibody Modalities
by: Xiangdan Wang, et al.
Published: (2020-03-01)

Gut microbiota: next frontier in understanding human health and development of biotherapeutics
by: Prakash S, et al.
Published: (2011-07-01)

Biosimilars
Published: (2022)

Factors that influence clinical efficacy of live biotherapeutic products
by: Bruno Pot, et al.
Published: (2021-05-01)

Significance of African Diets in Biotherapeutic Modulation of the Gut Microbiome
by: PO Isibor, et al.
Published: (2021-04-01)

Glycosylated Biotherapeutics: Immunological Effects of N-Glycolylneuraminic Acid
by: Sharon Yehuda, et al.
Published: (2020-01-01)

Immunogenicity to Biotherapeutics – the role of Anti-drug Immune complexes
by: Murli eKrishna, et al.
Published: (2016-02-01)

Population-specific design of de-immunized protein biotherapeutics.
by: Benjamin Schubert, et al.
Published: (2018-03-01)

Asymptomatic bacteriuria Escherichia coli are live biotherapeutics for UTI.
by: Charles N Rudick, et al.
Published: (2014-01-01)

Chrysophanol: A Natural Anthraquinone with Multifaceted Biotherapeutic Potential
by: Prateeksha, et al.
Published: (2019-02-01)

Biotherapeutics: Challenges and Opportunities for Predictive Toxicology of Monoclonal Antibodies
by: Dale E. Johnson
Published: (2018-11-01)

Antibody drug discovery: From Idea to Biotherapeutic Molecule
by: Davis, Katherine A. D
Published: (2016)

Recent Advances in the Molecular Design and Applications of Multispecific Biotherapeutics
by: Xiaotian Zhong, et al.
Published: (2021-03-01)

Microneedle-mediated transdermal drug delivery of biotherapeutic macromolecules
by: Courtenay, Aaron John
Published: (2016)